Associations of Per- and Polyfluoroalkyl Substances with Maternal Early Second Trimester Sex-steroid Hormones

Overview

Journal Int J Hyg Environ Health

Specialties Environmental Health
Public Health

Date 2024 Apr 24

PMID 38657330

Authors

Diana C Pacyga

George D Papandonatos

Libeth Rosas

Jason Whalen

Sabrina Smith

June-Soo Park

Joseph C Gardiner

Joseph M Braun

Susan L Schantz

Rita S Strakovsky

Affiliations

Soon will be listed here.

Abstract

Background/aims: Pregnant women are exposed to persistent environmental contaminants, including per- and polyfluoroalkyl substances (PFAS) that disrupt thyroid function. However, it is unclear if PFAS alter maternal sex-steroid hormone levels, which support pregnancy health and fetal development.

Methods: In Illinois women with relatively high socioeconomic status (n = 460), we quantified perfluorononanoic (PFNA), perfluorooctane sulfonic (PFOS), perfluorooctanoic (PFOA), methyl-perfluorooctane sulfonamide acetic acid, perfluorohexanesulphonic (PFHxS), perfluorodecanoic (PFDeA), and perfluoroundecanoic (PFUdA) acid concentrations in fasting serum samples at median 17 weeks gestation, along with plasma progesterone, testosterone, and estradiol. We evaluated covariate-adjusted associations of ln-transformed hormones with each ln-transformed PFAS individually using linear regression and with the PFAS mixture using quantile-based g-computation (QGComp).

Results: Interquartile range (IQR) increases in PFOS were associated with higher progesterone (%Δ 3.0; 95%CI: -0.6, 6.6) and estradiol (%Δ: 8.1; 95%CI: 2.2, 14.4) levels. Additionally, PFHxS was positively associated with testosterone (%Δ: 10.2; 95%CI: 4.0, 16.7), whereas both PFDeA and PFUdA were inversely associated with testosterone (%Δ: -5.7; 95%CI: -10.3, -0.8, and %Δ: -4.1; 95%CI: -7.6, -0.4, respectively). The IQR-standardized PFAS mixture was not associated with progesterone (%Δ: 1.6; 95%CI: -5.8, 9.2), due equal partial positive (%Δ: 9.2; driven by PFOA) and negative (%Δ: -7.4; driven by PFOS) mixture associations. Similarly, the mixture was not associated with testosterone (%Δ: 5.3; 95%CI: -9.0, 20.1), due to similar partial positive (%Δ: 23.6; driven by PFHxS) and negative (%Δ: -17.4; driven by PFDeA) mixture associations. However, we observed a slightly stronger partial positive (%Δ: 25.6; driven by PFOS and PFUdA) than negative (%Δ: -16.3; driven by PFOA) association resulting in an overall non-significant positive trend between the mixture and estradiol (%Δ: 8.5; 95%CI: -3.7, 20.9).

Conclusion: PFAS mixture modeled using QGComp was not associated with maternal sex-steroid hormones due to potential opposing effects of certain PFAS. Additional prospective studies could corroborate these findings.

References

VanderWeele T, Robins J . Signed directed acyclic graphs for causal inference. J R Stat Soc Series B Stat Methodol. 2014; 72(1):111-127. PMC: 4239133. DOI: 10.1111/j.1467-9868.2009.00728.x. View

Penny R, Parlow A, FRASIER S . Testosterone and estradiol concentrations in paired maternal and cord sera and their correlation with the concentration of chorionic gonadotropin. Pediatrics. 1979; 64(5):604-8. View

Coperchini F, Pignatti P, Lacerenza S, Negri S, Sideri R, Testoni C . Exposure to perfluorinated compounds: in vitro study on thyroid cells. Environ Sci Pollut Res Int. 2014; 22(3):2287-94. DOI: 10.1007/s11356-014-3480-9. View

Kang J, Choi J, Park J . Transcriptional changes in steroidogenesis by perfluoroalkyl acids (PFOA and PFOS) regulate the synthesis of sex hormones in H295R cells. Chemosphere. 2016; 155:436-443. DOI: 10.1016/j.chemosphere.2016.04.070. View

Londero A, Rossetti E, Pittini C, Cagnacci A, Driul L . Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study. BMC Pregnancy Childbirth. 2019; 19(1):261. PMC: 6651936. DOI: 10.1186/s12884-019-2400-x. View

Colles A, Bruckers L, Den Hond E, Govarts E, Morrens B, Schettgen T . Perfluorinated substances in the Flemish population (Belgium): Levels and determinants of variability in exposure. Chemosphere. 2020; 242:125250. DOI: 10.1016/j.chemosphere.2019.125250. View

Liu H, Pan Y, Jin S, Li Y, Zhao L, Sun X . Associations of per-/polyfluoroalkyl substances with glucocorticoids and progestogens in newborns. Environ Int. 2020; 140:105636. DOI: 10.1016/j.envint.2020.105636. View

Zheng B, Sun X, Xian J, Niu P . Maternal Testosterone and Offspring Birth Weight: A Mendelian Randomization Study. J Clin Endocrinol Metab. 2022; 107(9):2530-2538. DOI: 10.1210/clinem/dgac389. View

Amrhein V, Greenland S, McShane B . Scientists rise up against statistical significance. Nature. 2019; 567(7748):305-307. DOI: 10.1038/d41586-019-00857-9. View

10.

Lebeaux R, Doherty B, Gallagher L, Zoeller R, Hoofnagle A, Calafat A . Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study. Environ Res. 2020; 185:109395. PMC: 7657649. DOI: 10.1016/j.envres.2020.109395. View

11.

Yu W, Liu W, Jin Y . Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem. 2008; 28(5):990-6. DOI: 10.1897/08-345.1. View

12.

Braun J, Gennings C, Hauser R, Webster T . What Can Epidemiological Studies Tell Us about the Impact of Chemical Mixtures on Human Health?. Environ Health Perspect. 2016; 124(1):A6-9. PMC: 4710611. DOI: 10.1289/ehp.1510569. View

13.

Kummu M, Sieppi E, Koponen J, Laatio L, Vahakangas K, Kiviranta H . Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system. Placenta. 2015; 36(10):1185-91. DOI: 10.1016/j.placenta.2015.07.119. View

14.

Zhang C, Sundaram R, Maisog J, Calafat A, Barr D, Buck Louis G . A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes. Fertil Steril. 2014; 103(1):184-9. PMC: 4282598. DOI: 10.1016/j.fertnstert.2014.10.001. View

15.

Bjorke-Monsen A, Varsi K, Averina M, Brox J, Huber S . Perfluoroalkyl substances (PFASs) and mercury in never-pregnant women of fertile age: association with fish consumption and unfavorable lipid profile. BMJ Nutr Prev Health. 2021; 3(2):277-284. PMC: 7841832. DOI: 10.1136/bmjnph-2020-000131. View

16.

Pacyga D, Gardiner J, Flaws J, Li Z, Calafat A, Korrick S . Maternal phthalate and phthalate alternative metabolites and urinary biomarkers of estrogens and testosterones across pregnancy. Environ Int. 2021; 155:106676. PMC: 8292204. DOI: 10.1016/j.envint.2021.106676. View

17.

Laraia B, Bodnar L, Siega-Riz A . Pregravid body mass index is negatively associated with diet quality during pregnancy. Public Health Nutr. 2007; 10(9):920-6. DOI: 10.1017/S1368980007657991. View

18.

Du G, Hu J, Huang H, Qin Y, Han X, Wu D . Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo. Environ Toxicol Chem. 2012; 32(2):353-60. DOI: 10.1002/etc.2034. View

19.

Fisher M, Arbuckle T, Lei Liang C, LeBlanc A, Gaudreau E, Foster W . Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study. Environ Health. 2016; 15(1):59. PMC: 4855498. DOI: 10.1186/s12940-016-0143-y. View

20.

Huang R, Chen Q, Zhang L, Luo K, Chen L, Zhao S . Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy. Environ Health. 2019; 18(1):5. PMC: 6327470. DOI: 10.1186/s12940-018-0445-3. View